Dr. Filipe Pereira is an Associate Professor at the Lund Stem Cell Center at Lund Unversity. His research focuses on how hematopoietic cell fate is specified, maintained, and eventually modified or reversed. His lab uses an interdisciplinary approach to mechanistically understand hematopoietic and immune cell identities and translate their findings into novel gene and cell therapies.

Read his recent paper on the development of a protocol for direct reprogramming of mouse embryonic fibroblasts to conventional tyle 1 dendritic cells disorders here.

Listen to the episode here.